Publications

« 1999 »

• Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
  Jozkowicz A, Pankiewicz J, Dulak J, Partyka L, Wybranska I, Huk I, Dembinska-Kiec A.
  Acta Biochim Pol. 1999;46(3):703-15.
  PMID: 10698278
• Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase--implications for gene therapy in cardiovascular diseases.
  Dulak J, Jozkowicz A, Guevara I, Dembinska-Kiec A.
  Pol J Pharmacol. 1999 May-Jun;51(3):233-41.
  PMID: 10600037
• Oxidized low density lipoprotein inhibits inducible nitric oxide synthase, GTP cyclohydrolase I and transforming growth factor beta gene expression in rat macrophages.
  Dulak J, Polus M, Guevara I, Hartwich J, Wybranska I, Krzesz R, Dembinska-Kiec A.
  J Physiol Pharmacol. 1999 Sep;50(3):429-41.
  PMID: 10574472
• Expression of beta-galactosidase gene and endothelial nitric oxide synthase gene in rat vascular smooth muscle cells after in vitro lipotransfection.
  Jozkowicz A, Dulak J, Guevara I, Wybranska I, Dembinska-Kiec A.
  Clin Chim Acta. 1999 Oct;288(1-2):1-19.
  PMID: 10529453
• Gene transfer of nitric oxide synthase: effects on endothelial biology.
  Niebauer J, Dulak J, Chan JR, Tsao PS, Cooke JP.
  J Am Coll Cardiol. 1999 Oct;34(4):1201-7.
  PMID: 10520813
• Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification.
  Sacha T, Dulak J, Skotnicki AB, Dembinska-Kiec A.
  Przegl Lek. 1999;56 Suppl 1:57-61. Review. Polish.
  PMID: 10494184